Cebiosys

GeneProof Epstein-Barr Virus (EBV) PCR Kit

Katalógus szám : EBV/ISEX/100
Cikkszám: EBV/ISEX/100 Kategóriák: ,

Gyártó: GeneProof a.s.

 

A termék CE/IVD minősítéssel rendelkezik és az OGYÉI által nyilvántartásba vett.

Az Epstein-Barr vírus detektálására alkalmas ‘Ready-to-Use ‘ master mix. A nukleáris antigén 1-et (EBNA1) kódoló gén, egyetlen kópiájú DNS szekvenciáját célozza. (100 reakció)

 

 

Leírás

Ugrás a gyártó weboldalára

PRODUCT ADVANTAGES

 

PART OF I/T PANEL

  • Easily combinable with other PCR kits from the Immunocompromised / Transplanted Panel in one workflow
  • Simplifies laboratory workflow

EASY-TO-USE CONCEPT

  • Single tube ready-to-use Master Mix contains all components for PCR amplification
  • No additional PCR reagents pipetting necessary

CONTAMINATION PREVENTION

  • Ready-to-Use Master Mix contains Uracil-DNA glycosylase (UNG) and dUTPs eliminating possible carryover contamination

W.H.O. STANDARD BASED QUANTIFICATION

  • Precise and fully traceable quantification according to WHO 1st International Standard NIBSC 09/260

COMPATIBLE WITH A WIDE RANGE OF REAL-TIME PCR DEVICES

CE IVD CERTIFIED DIAGNOSTIC TEST

Technical specification

Indication in vitro diagnostic medical device
Intended User For professional use in laboratories with trained staff
Technology real-time PCR
Type of Analysis qualitative and quantitative
Target Sequence DNA sequence of the single copy gene encoding the nuclear antigen 1 (EBNA1)
Analytical Specificity Epstein-Barr virus, 100 %
Analytical Sensitivity (LoD) reaches up to 196.088 IU/ml with the probability of 95 % (on NIBSC EBV 09/260 using manual extraction GeneProof PathogenFree DNA Isolation Kit)
reaches up to 289.46 IU/ml with the probability of 95 % (on NIBSC EBV 09/260 using automatic extraction
croBEE NA16 Nucleic Acid Extraction System)
Diagnostic Specificity 100 % (CI95 % : 83.98 % – 100 %) according to EQA panels results
90.91 % (CI95 % : 79.29 % – 96.60 %) according to Clinical performance analysis 2019
Diagnostic Sensitivity 100 % (CI95 % : 96.53 % – 100 %) according to EQA panels results
98.08 % (CI95 % : 88.42 % – 99.90 %) according to Clinical performance analysis 2019
Linear Range 1010 – 102.5 IU/ml with precision of ± 0.5 log (using manual extraction GeneProof PathogenFree DNA Isolation Kit)
1010 – 102.5 IU/ml with precision of ± 0.5 log (using automatic extraction croBEE 201A Nucleic Acid Extraction Kit)
Dynamic Range 1010 – 196.088 IU/ml (using manual extraction GeneProof PathogenFree DNA Isolation Kit)
1010 – 289.46 IU/ml (using automatic extraction croBEE NA16 Nucleic Acid Extraction System)
Reporting Units cp/μl
Conversion Factor 1 IU = 1 cp
Metrological Traceability EBV NIBSC 09/260
Extraction / Inhibition Control PCR inhibition and DNA extraction efficiency control (ISEX version)
Validated Specimen CSF, plasma, whole blood, BAL
Storage -20 ± 5 °C
Validated Extraction Method croBEE 201A Nucleic Acid Extraction Kit
GeneProof PathogenFree DNA Isolation Kit
Instruments croBEE Real-Time PCR System
Applied Biosystems 7300 / 7500 Real-Time PCR System
AriaMx Real-Time PCR System
CFX Connect™ / CFX96™ / Dx Real-Time PCR Detection System
LightCycler® 2.0 / 480
LineGene 9600 / 9600 Plus
Mic qPCR Cycler
QuantStudio™ 3 / 5 Real-Time PCR System
Rotor-Gene 3000 / Q
SLAN® Real-Time PCR System
Montania 4896 Real-Time PCR termocykler
StepOne™ / StepOnePlus™ Real-Time PCR System
Required Detection Channels FAM, HEX
External Quality Assessment Regularly tested by QCMD and Instand e.V. External Quality Assessment panels – results at www.geneproof.com
Regulatory Status CE IVD

Kapcsolódó termékek